Cell lines and growth conditions. A YBX1-null cell line was previously generated by transiently transfecting a pX330-based plasmid expressing Cas9, a YBX1 guide RNA and a Venus reporter to sort for transfected cells (1). 48-h post-transfection Venus-positive cells were sorted as single cells, clonally expanded and screened for homozygous deletions at the YBX1 genomic locus by PCR and for expression of YBX1 by immunoblot (2). Wild-type HEK293T and YBX1-null cells were cultured in Dulbecco's modified Eagle medium with 10% fetal bovine serum (Thermo Fisher Scientific, Waltham, MA). For EV production, cells were seeded at ~10% confluency in 150-mm CellBIND tissue culture dishes (Corning, Corning NY) containing 30 ml of growth medium and grown to 80% confluency (~48 h). Cells grown for EV production were incubated in exosome-free medium produced by ultracentrifugation at 100,000Xg (28,000 RPM) for 18 h using an SW-28 rotor (Beckman Coulter, Brea, CA) in a LE-80 ultracentrifuge (Beckman Coulter) to deplete cow EVs present in fetal calf serum. Most abundant human and bovine tRNA species have identical sequences. However, examination of RNY3 and RNY4, each of which has two nucleotide differences between humans and cows, indicated that contamination of HEK293T cell EVs/exosomes by bovine exosomal RNAs was minimal (0.3-1%, 1-1.2%, and 2.5-4% in the EVR1, GRV, and WEX datasets, respectively; Tables S1-S3).
using a fixed angle FIBERlite F14-6X500y rotor (Thermo Fisher Scientific). The supernatant fraction was then passed through a 0.22 µM polystyrene vacuum filter (Corning) and centrifuged at ~100,000Xg (26,500 RPM) for 1.5 h using two SW-28 rotors. The pellet material was resuspended by adding 500 µl of phosphate buffered saline, pH 7.4 (PBS), to the pellet of each tube followed by trituration using a large bore pipette over a 30-min period at 4 ºC. The resuspended material was washed with ~5 ml of PBS and centrifuged at ~120,000Xg (36,500 RPM) in an SW-55 rotor (Beckman Coulter). Washed pellet material was then resuspended in 200 µl PBS as in the first centrifugation step and 1 ml of 60% sucrose buffer (20 mM Tris-HCl, pH 7.4, 137 mM NaCl) was added and vortexed to mix the sample evenly. The sucrose concentration in the PBS/sucrose mixture was measured by refractometry and, if necessary, additional 60% sucrose buffer was added until the concentration was >48%. Sucrose buffers (40%, 20% and 0% -1 ml each) were sequentially overlaid on the sample and the tubes were centrifuged at ~150,000Xg (38,500 RPM) for 16 h in an SW-55 rotor. The 20/40% interface fraction was collected and either subjected to nuclease protection assays or, for preparation of
CD63
+ exosomes, diluted 1:5 with PBS followed by addition of 1 µg of rabbit polyclonal anti-CD63 H-193 (Santa Cruz Biotechnology, Dallas, TX) per liter of original conditioned medium and mixed by rotation for 2 h at 4 ºC. Magvigen protein-A/G conjugated magnetic beads (Nvigen, Sunnyvale, CA) were then added to the exosome/antibody mixture and mixed by rotation for 2 h at 4 ºC. Beads with bound exosomes were washed three times in 1 ml PBS and RNA was extracted by using a Direct-Zol RNA mini-prep kit (Zymo Research, Irvine, CA).
Isolated EVs were routinely assessed for quality by sizing and quantitation on a Nanosight NS300 system (Malvern Instruments, UK). EVs generally ranged from 50-150 nm with a mean of 90-100 nm. Samples showing distinct peaks above and below this range were discarded.
Nuclease-protection experiments. Post-flotation EV fractions from the 20/40% sucrose gradient interface (100 µl) were mixed with Triton X-100 (TX-100; 10 µl 10% in 20 mM TrisHCl, pH 7.4, 137 mM NaCl) or buffer alone. The mixture was then briefly mixed by vortexing and incubated on ice for 30 min. Proteinase K was added to a final concentration of 10 µg/ml to some samples, incubated on ice for 30 min and inactivated by the addition of phenylmethlysufonyl fluoride (PMSF) (5 mM). RNase If (40 U) and 11 µl of New England
Biolabs Buffer 3 were then added and incubation was continued at 30 ºC for 20 min.
Alternatively, Turbo DNase (2 U; Thermo Fisher Scientific) and 11 µl of Turbo DNase buffer were added and the solution was incubated at 37 ºC for 30 min. Enzymes were inactivated by the addition of 700 µl of Trizol and RNA extraction was performed with the Direct-Zol RNA mini kit (Zymo Research).
RNA-seq library preparation using thermostable group II intron reverse transcriptase (TGIRT-seq). TGIRT-seq libraries were prepared from 1-3 ng of EV or CD63 + -exosomal RNA extracted as described above using the TGIRT total RNA-seq method (3-5). Where indicated, RNAs were treated with DNase I (Zymo Research, manufacturer's conditions) prior to library construction. For the GEV-3'P dataset (Table S2) nucleotides (e.g., CCA and poly(U)), short untrimmed adapter sequences, or non-templated nucleotides added to the 3' end of the cDNAs by TGIRT enzymes (denoted Pass 2). The uniquely mapped reads from Passes 1 and 2 were combined by using Samtools. To process multiply mapped reads, we collected up to 10 distinct alignments with the same mapping score and selected the alignment with the shortest distance between the two paired ends (i.e., the shortest read span). In the case of ties between reads mapping to rRNA and non-rRNA sequences, the read was assigned to the rRNA sequence, and in other cases, the read was assigned randomly to one of the tied choices. Uniquely mapped reads and the filtered multiply mapped reads were combined and intersected with gene annotations (Ensembl GRCh38 Release 76), with RNY5 gene and its 10 pseudogenes, which are not annotated in this release, added manually to generate the counts for individual features. Coverage of each feature was calculated by Bedtools. To avoid mis-counting reads with embedded sncRNAs, reads were first intersected with sncRNA annotations and the remaining reads were then intersected with the annotations for protein-coding genes, lincRNAs, antisense, and other lncRNAs. To further improve the mapping rate for tRNAs and rRNAs, we combined reads that were uniquely or multiply mapped to tRNAs or rRNAs in the initial alignments and re-mapped them to tRNA reference sequences (Genomic tRNA Database, and UCSC genome browser website) or rRNA reference sequences (GeneBank:
X12811 and U13369) using Bowtie 2 local alignment. Because similar or identical tRNAs with the same anticodon may be multiply mapped to different tRNA loci by Bowtie 2, mapped tRNA reads were combined according to their tRNA anticodon (N = 55) prior to calculating the tRNA distributions. The 55 anticodons included 48 commonly used tRNA anticodons, iMetCAT, SelCysTCA, two families of suppressive tRNAs with anticodons corresponding to stop codons (SupCTA and SupTTA), a family of tRNAs with an undetermined anticodon and two predicted tRNAs (CysACA and SerACT). Coverage plots and read alignments were created by using
Integrative Genomics Viewer (IGV) (6). Genes with >1,000 mapped reads were down sampled to 1,000 mapped reads in IGV for visualization. For correlation analysis, RNA-seq datasets were normalized for the total number of mapped reads by using DESeq2 (7) and plotted in R. To identify putative mRNAs, we remapped reads that mapped to protein-coding genes in the initial mapping pipeline to the human transcriptome reference (Ensembl GRCh38 releae 76). Reads from different transcript isoforms of the same gene were combined for count normalization in scatter plots. Reads that mapped to putative mRNAs in the human transcriptome reference were retrieved and remapped to the human genome reference using HISAT2 and analyzed by picardtools to calculate the percentage of bases in CDS, UTR, intron, and intergenic regions.
Reverse transcription PCR.
EVs were isolated and left untreated or treated with RNase I f and/or detergent as described above. RNA was extracted using the Zymo RNA miniprep kit according to the manufacturer's instructions. 10 ng of EV or whole cell RNA was reverse transcribed using the SuperScript IV cDNA synthesis kit (Thermo Fisher Scientific) with the supplied oligo(dT) primer. PCR was performed using primers that spanned at least two splice ºC for 30 sec) with a final extension at 72 ºC for 2 min using GoTaq DNA polymerase (Promega). PCR products were separated on a 2.5% agarose gel and visualized using GelRed TGIRT-seq libraries were prepared by using GsI-IIC RT (TGIRT-III) from RNA extracted from HEK293T cell EVs that were either untreated or treated with protease, detergent (TX-100), RNase or DNase alone or in combination, as indicated in the Table, and then sequenced on an Illumina NextSeq 500 instrument to obtain the indicated numbers of 75-nt paired-end reads. The reads were trimmed to remove adapter sequences and low quality base calls (sequencing quality cutoff 20, p < 0.01), and reads <15 nt after trimming were discarded. Trimmed reads were then mapped by using HISAT2 and Bowtie2 to a human genome reference sequence (Ensembl GRCh38) modified to include additional rRNA repeats. The loss of reads after trimming for the EVR samples likely reflects incomplete removal of adapter dimers from libraries prepared from small amounts of EV RNA. The dataset name is given above and the laboratory notebook sample identification is given below. TGIRT-seq libraries were prepared by using either GsI-IIC RT (TGIRT-III) or TeI4c RT from unfragmented HEK293T whole cell RNA or RNA extracted from EVs from the same culture. The cellular RNA libraries (GC and TC) were sequenced on an Illumina HiSeq 2500 to obtain the indicated numbers of 125-nt pair-end reads, and the EV RNAs (GEV, GEV-3'P and TEV) were sequenced on an Illumina NextSeq 500 to obtain the indicated numbers of 150-nt single-end reads. The reads were trimmed to remove adapter sequences and low quality base calls (sequencing quality cutoff 20, p < 0.01), and reads <15 nt after trimming were discarded. Trimmed reads were then mapped by using HISAT2 and Bowtie2 to a human genome reference sequence (Ensembl GRCh38) modified to include additional rRNA repeats. The dataset name is given above and the laboratory notebook sample identification is given below. TGIRT-seq libraries were prepared from DNase-treated HEK293T whole cell RNA (fragmented or unfragmented, as indicated in the Table, and from DNase-treated RNA extracted from CD63 + exosomes from the same cultures by using TGIRT-III and sequenced on an Illumina NextSeq 500 instrument to obtain the indicated numbers of 75-nt paired-end reads. The reads were trimmed to remove adapter sequences and low quality base calls (sequencing quality cutoff 20, p < 0.01), and reads <15 nt after trimming were discarded. Trimmed reads were then mapped by using HISAT2 and Bowtie2 to a human genome reference sequence (Ensembl GRCh38) modified to include additional rRNA repeats. The dataset name is given above and the laboratory notebook sample identification is given below. Figure S3 . Scatter plots comparing the relative abundance of different tRNA species in EVs and exosomes with that in the cells from which the EVs were isolated. (A) Scatter plots of DESeq2-normalized reads counts in EV and unfragmented whole cell RNA (datasets GEVand GC, respectively; Table S2 ). (B) Scatter plots of DESeq2-normalized read counts in exosomes and unfragmented whole cell RNA (datasets WEX and WC, respectively; Table S3 ). tRNAs are grouped by anticodon and color coded according the type of amino acid. Spearman's correlation coefficients (r) are shown in the upper left corner of each plot. Figure S14. IGV screen shots showing (A) read coverage across the tRNA coding sequence for valine isoacceptor TAC from TGIRT-seq of EV and unfragmented whole cell RNA using GsI-IIC RT or TeI4c RT and (B) read coverage across the genomic sequence for precursor tRNAs for LysCTT (Fig. 7B) and ValTAC (this Figure, panel A) from TGIRT-seq of unfragmented whole cell RNA using TeI4c RT. The genomic sequences in panel B consist of the tRNA coding sequence plus 15 bp of flanking genomic sequences retrieved from the UCCS genome browser for tRNA gene loci indicated below the alignments. Coverage plots are above the read alignments with reads sorted by top strand position. The numbers of reads are indicated to the left of the coverage plot and were down sampled to 1,000 reads in IGV for visualization. Nucleotides in reads matching nucleotides in the annotated reference are colored gray. Nucleotides in reads that do not match the annotated reference are color coded by nucleotide (A, green; C, blue; G, brown; and T, red). The 1-methyladenine (m 1 A) and the 3' CCA posttranscriptional modifications, extra non-templated nucleotides added to the 3' end of the cDNA by the RT, and the D-loop truncation (U16) are indicated. Reads identified as tRNA precursors have short 5'-and 3'-end extensions that appear as additional unmapped sequences at both ends of the tRNA sequence when mapped to the tRNA coding sequence (Fig. 7B , and this Figure, 
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